Other Disorders

Table 6. HTC Population Profile Patient Characteristics, Other Disorders, Data Reported From 1/1/2012 Through 9/29/2017

HTC Population Profile Patient Characteristics, Other Disorders
Venous
thromboembolism
Blood coagulation
disorder without
specific diagnosis
Ehlers-Danlos
syndrome
# (%) # (%) # (%)
# of patients 19140 (100) 1170 (100) 195 (100)
Age (years) <2 1503 (8) 64 (5) * *
2-10 1417 (7) 375 (32) 28 (14)
11-19 3045 (16) 340 (29) 87 (45)
20-44 5088 (27) 198 (17) 56 (29)
45-64 5291 (28) 120 (10) 21 (11)
65+ 2796 (15) 73 (6) * *
Sex Male 8389 (44) 427 (36) 48 (25)
Female 10751 (56) 743 (64) 147 (75)
Ethnicity Hispanic, Latino/a, or Spanish origin 1562 (8) 339 (29) 6 (3)
Not Hispanic, Latino/a, or Spanish origin 17190 (90) 794 (68) 178 (91)
Unknown 388 (2) 37 (3) 11 (6)
Race American Indian/Alaska Native 71 (0) 14 (1) * *
Asian 332 (2) 41 (4) * *
Black or African American 3221 (17) 82 (7) * *
Native Hawaiian or other Pacific Islander 39 (0) * * * *
White 14927 (78) 953 (81) 179 (92)
More than one of these 94 (0) * * * *
Unknown 456 (2) 67 (6) 9 (5)
Insurance Status Insured 18821 (98) 1157 (99) 194 (99)
Uninsured 252 (1) * * * *
Unknown 67 (0) * * * *
History of HCV infection Yes * * 11 (1) * *
No * * 925 (79) 131 (67)
Unknown * * 234 (20) * *
Not Applicable 19140 (100) 0 (0) 0 (0)
History of HIV infection Yes * * * * * *
No * * 931 (80) 132 (68)
Unknown * * * * * *
Not Applicable 19140 (100) 0 (0) 0 (0)

† The HTC Population Profile contains 30 transsexual individuals. For confidentiality purposes, the number of transsexual patients is too small to report by year or other characteristics. Transsexual patients have been included in the counts of male and female according to the sex assigned to them at birth since hemophilia and von Willebrand disease, the most common congenital bleeding disorders, affect the sexes differently.

* Counts of five or fewer have been suppressed to protect patient confidentiality. Additional cells may be suppressed to prevent derivation of these counts by subtraction.

‡ HCV and HIV status are not recorded for VTE patients.